June 25, 2026

Underdog role is unfamiliar for Ohio State, but Buckeyes have thrived as one in CFP

GlobeNewswire Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE Ødegård Prosjekt AS, a wholly owned company of Jon Olav Ødegård has today, 30 December 2022, bought 70,000 shares at an average price of NOK 2.91 per share. Jon Olav Ødegård is CEO and primary insider of Hofseth BioCare ASA. After the transaction, Ødegård Prosjekt AS holds 2,964,039 shares, including 860,000 shares held indirectly through ownership in Brilliant Invest AS. Mr. Ødegård also holds 1,000,000 share options, totalling 4,034,039 shares and share options corresponding to approx. 1.0 % o

Continue Reading: Underdog role is unfamiliar for Ohio State, but Buckeyes have thrived as one in CFP